Integra LifeSciences (IART)
(Real Time Quote from BATS)
$29.25 USD
+0.15 (0.50%)
Updated Apr 23, 2024 09:48 AM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IART 29.25 +0.15(0.50%)
Will IART be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IART based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IART
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
IART: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Investors Should Retain Integra (IART) Stock Now
Why Is Integra (IART) Down 4% Since Last Earnings Report?
Integra LifeSciences (IART) Introduces MicroMatrix Flex
Other News for IART
First Week of December 20th Options Trading For Integra LifeSciences Holdings (IART)
Jefferies Sticks to Their Buy Rating for Integra Lifesciences (IART)
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
ClearBridge Small Cap Growth Strategy Q2 2024 Portfolio Manager Commentary
Top buy-rated stocks and sell-rated stocks within Health Care - Citi